10-Q: RGA Reports Mixed Q2 2025 Results Amid Strategic Reinsurance Expansion and Capital Initiatives
Quarterly Report
Reinsurance Group of America, Incorporated reported increased six-month net income and EPS, driven by improved investment performance, despite a decline in adjusted operating income and the execution of a large new reinsurance transaction with Equitable Holdings.
Summary
- Net income available to RGA, Inc. shareholders increased to $466 million for the six months ended June 30, 2025, up from $413 million in the prior year period.
- Diluted earnings per share for the six months ended June 30, 2025, rose to $6.97, compared to $6.19 in the same period of 2024.
- Net income available to RGA, Inc. shareholders decreased to $180 million for the three months ended June 30, 2025, down from $203 million in the prior year period.
- Diluted earnings per share for the three months ended June 30, 2025, decreased to $2.70, compared to $3.03 in the same period of 2024.
- Adjusted operating income before income taxes decreased to $906 million for the six months ended June 30, 2025, from $1,007 million in the prior year period, and to $421 million for the three months ended June 30, 2025, from $491 million.
- Total assets increased to $133.5 billion as of June 30, 2025, from $118.7 billion at December 31, 2024.
- Total RGA, Inc. shareholders' equity increased to $12.1 billion as of June 30, 2025, from $10.8 billion at December 31, 2024.
- Net premiums decreased by $1,126 million for the six months ended June 30, 2025, primarily due to single premium pension risk transfer (PRT) transactions completed in 2024.
- Net investment income increased by $597 million for the six months ended June 30, 2025, driven by a larger invested asset base and higher new money rates.
- Investment related losses, net, decreased by $297 million for the six months ended June 30, 2025, reflecting lower unfavorable impacts from portfolio repositioning and freestanding derivatives.
- A 75% quota share of Equitable Holdings, Inc.'s in-force individual life insurance liabilities, approximately $32 billion on a U.S. statutory basis, was assumed on July 31, 2025, with an estimated $11 billion to $12 billion in liabilities and assets reflected on the consolidated balance sheet.
Sentiment
Score: 6
Explanation: The company reported mixed financial results with a decline in adjusted operating income for both periods and a decrease in net income for the quarter, primarily due to unfavorable claims and increased costs. However, six-month net income and EPS increased, driven by strong investment performance and reduced investment losses. The company also demonstrated proactive capital management with new debt issuance and a significant reinsurance transaction, indicating strategic growth despite some operational headwinds.
Positives
- Net income available to shareholders increased by $53 million for the six months ended June 30, 2025, reaching $466 million.
- Diluted earnings per share increased by $0.78 to $6.97 for the six months ended June 30, 2025.
- Net investment income significantly increased by $597 million for the six months ended June 30, 2025, and $326 million for the three months, driven by a larger invested asset base and higher new money rates.
- Investment related losses, net, improved substantially, decreasing by $297 million for the six months and $227 million for the three months ended June 30, 2025, compared to prior periods.
- Total assets grew by $14.8 billion to $133.5 billion as of June 30, 2025.
- Total RGA, Inc. shareholders' equity increased by $1.2 billion to $12.1 billion as of June 30, 2025.
- Cash and cash equivalents increased by $2.1 billion to $5.4 billion as of June 30, 2025.
- Organic growth and new business production in life reinsurance in force totaled $242.6 billion for the six months ended June 30, 2025.
- Issued $700 million in 6.65% fixed-rate reset subordinated debentures due 2055, strengthening capital for general corporate purposes and the Equitable transaction.
- Entered into a 30-year facility agreement for up to $1.0 billion of 6.722% senior notes due 2055, providing a future liquidity option.
- Maintained compliance with all debt covenants.
- Management believes current liquidity sources are sufficient for the next 12 months, even under stress scenarios.
- Quarterly dividend increased to $0.93 per share in July 2025.
Negatives
- Net income available to shareholders decreased by $23 million for the three months ended June 30, 2025, to $180 million.
- Diluted earnings per share decreased by $0.33 to $2.70 for the three months ended June 30, 2025.
- Adjusted operating income before income taxes decreased by $101 million for the six months and $70 million for the three months ended June 30, 2025.
- Unfavorable claims experience in the U.S. Traditional segment contributed to the decrease in adjusted operating income.
- Future policy benefits remeasurement resulted in losses of $12 million for the six months and $68 million for the three months ended June 30, 2025, compared to gains in the prior year periods.
- Increased operating and financing costs impacted profitability.
- Gross unrealized losses on fixed maturity securities increased from $6.4 billion at December 31, 2024, to $6.9 billion at June 30, 2025.
- The effective tax rate increased to 47.0% for the three months and 34.1% for the six months ended June 30, 2025, primarily due to tax expense related to legal entity restructuring and valuation allowance on foreign tax credit carryforwards.
Risks
- Adverse changes in mortality, morbidity, lapsation, or claims experience.
- Inadequate risk analysis and underwriting processes.
- Adverse capital and credit market conditions impacting liquidity, access to capital, and cost of capital.
- Changes in financial strength and credit ratings, affecting future results and financial condition.
- Availability and cost of collateral necessary for regulatory reserves and capital.
- Requirements to post collateral or make payments due to declines in the market value of assets subject to collateral arrangements.
- Actions by regulators in jurisdictions where reinsurance operations occur.
- Impact of the parent company's status as an insurance holding company and regulatory restrictions on debt obligations.
- General economic conditions or prolonged economic downturns affecting demand for insurance and reinsurance.
- Impairment of other financial institutions affecting business.
- Fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets.
- Market or economic conditions adversely affecting investment security values or resulting in impairments.
- Market or economic conditions adversely affecting the ability to make timely sales of investment securities.
- Risks inherent in risk management and investment strategy, including changes in investment portfolio yields.
- Subjectivity in determining allowances and impairments on investments.
- Stability of governments and economies in operating markets, including U.S. sovereign debt uncertainties.
- Dependence on third parties, including ceding companies, reinsurers, and investment managers.
- Financial performance of clients.
- Threat of natural disasters, catastrophes, terrorist attacks, pandemics, epidemics, or other major public health issues.
- Competitive factors and competitors' responses.
- Development and introduction of new products and distribution opportunities.
- Execution of entry into new markets.
- Integration of acquired blocks of business and entities.
- Interruption or failure of telecommunication, information technology, or other operational systems, or failure to maintain adequate security.
- Adverse developments with respect to litigation, arbitration, or regulatory investigations or actions.
- Adequacy of reserves, resources, and accurate information relating to settlements, awards, and discontinued lines of business.
- Changes in laws, regulations, and accounting standards.
- Inability to achieve expected benefits from the Reinsurance Transaction with Equitable Holdings, Inc.
- Due diligence for the Reinsurance Transaction may not have revealed all relevant facts, leading to undiscovered obligations and liabilities.
- Assumptions relating to the Reinsurance Transaction (pricing, investment repositioning, future revenue/profitability, expenses, unknown liabilities, integration costs) may prove materially inaccurate.
- Exposure to mortality and lapse risk from the Reinsurance Transaction.
- Reliance on Equitable Holdings, Inc. for various services (policy administration, investment advice, execution) and potential responsibility for their acts or omissions.
- Assets backing modified coinsurance reserves retained by Equitable Holdings, Inc. are not expected to be available to RGA in case of Counterparty insolvency.
- Increased risk of loss if modified coinsurance assets are not managed in accordance with policy terms or regulatory requirements.
- Cybersecurity risks related to the Counterparty's information technology systems and data.
- Difficulties in integrating the risk assumed through the Reinsurance Transaction, potentially delaying or preventing anticipated benefits.
Future Outlook
The company anticipates that its cash flows and liquidity sources will be sufficient to meet requirements for the next twelve months, even under stress scenarios. It projects reserves to be sufficient and does not expect to need to augment capital, even if interest rates remain at current levels for the next five years, assuming other factors remain constant. The company continues to monitor new business opportunities and associated capital needs. The recently executed reinsurance contracts with Equitable Holdings, Inc. are expected to increase exposure to various risks but also contribute to business growth.
Management Comments
- "The Company believes that cash flows from the source of funds available to it will provide sufficient cash flows for the next twelve months to satisfy the current liquidity requirements of the Company under various scenarios that include the potential risk of early recapture of reinsurance treaties, market events and higher than expected claims."
- "The Company projects its reserves to be sufficient and does not expect to be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant."
- "Although management believes that the Companys current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape."
Industry Context
The company operates within the global life reinsurance and financial solutions industry, which is influenced by factors such as mortality and morbidity trends, interest rate fluctuations, and equity market volatility. The industry is also adapting to new regulatory frameworks like the Pillar II Global Minimum Tax and local tax regimes such as Bermuda's Corporate Income Tax Act of 2023. The company notes that while it has felt pressures from volatile interest rates and equity markets, its business is not overly sensitive to these, with mortality and morbidity risks remaining the most significant.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- Subject to litigation and regulatory investigations or actions from time to time.
- Management does not believe current loss contingencies will have a material adverse effect on financial condition, results of operations, or cash flows.
- A legal reserve is established when a loss is probable and estimable.
Related Party Transactions
- In 2022, Papara Financing LLC, a subsidiary of RGA Reinsurance Company, issued nonconvertible preferred interests to an unaffiliated third party, included in noncontrolling interest ($90 million).
- During the fourth quarter of 2023, Ruby Reinsurance Company (Ruby Re), a Missouri-domiciled life reinsurance company, was launched with the Company as a sponsor. The Company is not an investor in Ruby Re but has a ceded reinsurance recoverable from Ruby Re of approximately $2.7 billion as of June 30, 2025.
- Certain RGA subsidiaries have entered into intercompany securities lending agreements to more efficiently source securities for lending to third parties and for regulatory capital management.
Stakeholder Impact
- Shareholders are impacted by net income, EPS, dividends ($0.93/share declared), and the availability of the share repurchase program ($500M remaining).
- Employees received equity-based compensation awards (120,011 stock appreciation rights, 131,836 performance shares, 86,474 restricted stock units in Q1 2025).
- Clients (Ceding Companies) are impacted by new reinsurance contracts (e.g., Equitable transaction), financial solutions, and capital management support.
- Creditors are impacted by the long-term debt issuance ($700M debentures), compliance with debt covenants, and available credit facilities.
- Regulatory Bodies are impacted by compliance with SEC filing requirements, new accounting standards (Pillar II, Bermuda tax), and capital requirements.
Next Steps
- Continue to monitor new business opportunities and associated capital needs.
- Integrate the acquired liabilities and assets from the Equitable Holdings, Inc. reinsurance transaction.
- Manage the investment portfolio acquired in connection with the Reinsurance Transaction.
- Adopt new accounting standards: Income Taxes (December 31, 2025) and Disaggregation of Income Statement Expenses (December 31, 2027).
Key Dates
| Date | Description |
|---|---|
| December 1, 2020 | Date of Grant for Ron Herrmann's Restricted Stock Unit Agreement. |
| March 13, 2023 | Company entered into a syndicated revolving credit facility with a five-year term and $850 million capacity. |
| September 25, 2023 | Date of Grant for Mark Brooks' Restricted Stock Unit Agreement. |
| December 27, 2023 | Bermuda enacted the Corporate Income Tax Act of 2023. |
| January 1, 2024 | Effective date for Pillar II legislation in many jurisdictions and Bermuda corporate income tax regime. |
| January 23, 2024 | RGA's board of directors authorized a share repurchase program for up to $500 million. |
| February 2025 | RGA Reinsurance Company entered into a Master Transaction Agreement with subsidiaries of Equitable Holdings, Inc. |
| March 3, 2025 | Company issued $700 million in 6.65% fixed-rate reset subordinated debentures due 2055. |
| June 4, 2025 | Company entered into a 30-year facility agreement with a Delaware trust for up to $1.0 billion of 6.722% senior notes due 2055. |
| June 30, 2025 | End of the quarterly reporting period. |
| July 4, 2025 | The One Big Beautiful Bill Act (OBBB) was enacted. |
| July 21, 2025 | Date as of which 66,093,751 shares of common stock were outstanding. |
| July 31, 2025 | RGA Reinsurance Company executed Reinsurance Contracts with Equitable Holdings, Inc. subsidiaries. |
| August 1, 2025 | Date of filing for the 10-Q report. |
| December 1, 2025 | End of Vesting Period for Ron Herrmann's RSU award. |
| December 31, 2025 | Anticipated adoption date for the new Income Taxes accounting standard. |
| March 1, 2026 | Latest date for delivery of Common Stock for Ron Herrmann's RSU award. |
| September 25, 2026 | End of Vesting Period for Mark Brooks' RSU award. |
| December 31, 2027 | Anticipated adoption date for the new Disaggregation of Income Statement Expenses accounting standard. |
Recommendation
holdThe company presents a mixed financial picture with a decline in adjusted operating income and quarterly net income, offset by strong six-month net income growth and improved investment performance. The significant reinsurance transaction with Equitable Holdings, Inc. represents a strategic expansion but also introduces new integration and risk management challenges. While the company demonstrates robust liquidity and capital management, the operational headwinds and the inherent risks of a large new business integration suggest a "hold" position for investors seeking more consistent operational performance before considering further investment.
Keywords
Reinsurance, Life Insurance, Financial Solutions, Annuities, Pension Risk Transfer, SEC Filing, Quarterly Report, RGA, Investment Income, Earnings, Shareholder Equity, Capital Management, Debt, Derivatives, Mortality Risk, Lapse Risk, Equitable Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.